Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 302

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach2 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.

Behl, Christian, Moosmann, Bernd·2002·Free Radical Biology and Medicine
DOI 10.1016/s0891-5849(02)00883-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0891-5849(02)00883-3

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 66

  1. Sies, 1986, Biochemistry of oxidative stress, Angew. Chem. Intl. Ed. Engl, 25, 1058, 10.1002/anie.198610581 · DOI · Paper page
  2. Sies, 1993, Strategies of antioxidant defense, Eur. J. Biochem, 215, 213, 10.1111/j.1432-1033.1993.tb18025.x · DOI · Paper page
  3. Finkel, 2000, Oxidants, oxidative stress and the biology of ageing, Nature, 408, 239, 10.1038/35041687 · DOI · Paper page
  4. Halliwell, 1996, Antioxidants in human health and disease, Annu. Rev. Nutr, 16, 33, 10.1146/annurev.nu.16.070196.000341 · DOI · Paper page
  5. Markesbery, 1999, The role of oxidative stress in Alzheimer disease, Arch. Neurol, 56, 1449, 10.1001/archneur.56.12.1449 · DOI · Paper page
  6. Christen, 2000, Oxidative stress and Alzheimer disease, Am. J. Clin. Nutr, 71, 621S, 10.1093/ajcn/71.2.621s · DOI · Paper page
  7. Beal, 1995, Aging, energy, and oxidative stress in neurodegenerative disorders, Ann. Neurol, 38, 357, 10.1002/ana.410380304 · DOI · Paper page
  8. Behl, 1999, Alzheimer’s disease and oxidative stress, Prog. Neurobiol, 57, 301, 10.1016/S0301-0082(98)00055-0 · DOI · Paper page
  9. Harman, 1998, Aging, Ann. NY Acad. Sci, 854, 1, 10.1111/j.1749-6632.1998.tb09886.x · DOI
  10. Selkoe, 1999, Translating cell biology into therapeutic advances in Alzheimer’s disease, Nature, 399, A23, 10.1038/19866 · DOI
  11. Selkoe, 2001, Alzheimer’s disease, Physiol. Rev, 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
  12. Yankner, 1996, Mechanisms of neuronal degeneration in Alzheimers disease, Neuron, 16, 921, 10.1016/S0896-6273(00)80115-4 · DOI · Paper page
  13. Behl, 1997, Amyloid beta-protein toxicity and oxidative stress in Alzheimers-disease, Cell Tissue Res, 290, 471, 10.1007/s004410050955 · DOI · Paper page
  14. Yankner, 1989, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease, Science, 245, 417, 10.1126/science.2474201 · DOI · Paper page
  15. Yankner, 1989, Amyloid and Alzheimer’s disease—cause or effect?, Neurobiol. Aging, 10, 470, 10.1016/0197-4580(89)90101-2 · DOI
  16. Liu, 1997, Beta amyloid toxicity does not require rage protein, Biochem. Biophys. Res. Commun, 237, 37, 10.1006/bbrc.1997.7068 · DOI
  17. Wolozin, 2000, Mechanisms of neurodegenerative disorders, Arch. Neurol, 57, 801, 10.1001/archneur.57.6.801 · DOI
  18. Behl, 1997, Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro, Endocrinology, 138, 101, 10.1210/en.138.1.101 · DOI · Paper page
  19. Behl, 1997, Neuroprotection against oxidative stress by estrogens, Mol. Pharmacol, 51, 535, 10.1124/mol.51.4.535 · DOI · Paper page
  20. McGeer, 2000, Alzheimer disease and neuroinflammation, J. Neural Transm, 59, 53
  21. Cacabelos, 2000, Pharmacological treatment of Alzheimer disease, Drugs Today, 36, 415, 10.1358/dot.2000.36.7.589153 · DOI
  22. Janus, 2000, A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease, Nature, 408, 979, 10.1038/35050110 · DOI · Paper page
  23. Morgan, 2000, A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease, Nature, 408, 982, 10.1038/35050116 · DOI · Paper page
  24. Skovronsky, 2000, Beta-secretase revealed, Trends Pharmacol. Sci, 21, 161, 10.1016/S0165-6147(00)01467-X · DOI
  25. Breitner, 1996, The role of antiinflammatory drugs in the prevention and treatment of Alzheimer’s disease, Annu. Rev. Med, 47, 401, 10.1146/annurev.med.47.1.401 · DOI · Paper page
  26. McGeer, 1999, Brain inflammation in Alzheimer disease and the therapeutic implications, Curr. Pharm. Des, 5, 821, 10.2174/1381612805666230111212056 · DOI · Paper page
  27. Behl, 1992, Vitamin E protects nerve cells from amyloid β protein toxicity, Biochem. Biophys. Res. Commun, 186, 944, 10.1016/0006-291X(92)90837-B · DOI · Paper page
  28. Harris, 1995, Direct evidence of oxidative injury produced by the Alzheimer’s β-amyloid peptide (1–40) in cultured hippocampal neurons, Exp. Neurol, 131, 193, 10.1016/0014-4886(95)90041-1 · DOI · Paper page
  29. Behl, 1995, 17-β Estradiol protects neurons from oxidative stress-induced cell death in vitro, Biochem. Biophys. Res. Commun, 216, 473, 10.1006/bbrc.1995.2647 · DOI · Paper page
  30. Moosmann, 1999, The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties, Proc. Natl. Acad. Sci. USA, 96, 8867, 10.1073/pnas.96.16.8867 · DOI · Paper page
  31. Nakano, 1987, Novel and potent antioxidants on membrane phospholipid peroxidation, Biochem. Biophys. Res. Commun, 142, 919, 10.1016/0006-291X(87)91501-4 · DOI
  32. Sugioka, 1987, Estrogens as natural antioxidants of membrane phospholipid peroxidation, FEBS Lett, 210, 37, 10.1016/0014-5793(87)81293-0 · DOI · Paper page
  33. Goodman, 1996, Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons, J. Neurochem, 66, 1836, 10.1046/j.1471-4159.1996.66051836.x · DOI · Paper page
  34. Green, 1997, 17 Alpha-Estradiol exerts neuroprotective effects on SK-N-SH cells, J. Neurosci, 17, 511, 10.1523/JNEUROSCI.17-02-00511.1997 · DOI · Paper page
  35. Blum-Degen, 1998, Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death, Toxicol. Appl. Pharmacol, 152, 49, 10.1006/taap.1998.8503 · DOI
  36. Sagara, 1998, Induction of reactive oxygen species in neurons by haloperidol, J. Neurochem, 71, 1002, 10.1046/j.1471-4159.1998.71031002.x · DOI · Paper page
  37. Dubal, 1998, Estradiol protects against ischemic injury, J. Cereb. Blood Flow Metabol, 18, 1253, 10.1097/00004647-199811000-00012 · DOI · Paper page
  38. Wang, 1999, Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats, Stroke, 30, 630, 10.1161/01.STR.30.3.630 · DOI · Paper page
  39. Parthasarathy, 1999, Oxidants and antioxidants in atherogenesis, J. Lipid. Res, 40, 2143, 10.1016/S0022-2275(20)32089-7 · DOI · Paper page
  40. Moosmann, 1997, Neuroprotective potential of aromatic alcohols against oxidative cell death, FEBS Lett, 413, 467, 10.1016/S0014-5793(97)00961-7 · DOI
  41. Skaper, 1997, Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion, Free Radic. Biol. Med, 22, 669, 10.1016/S0891-5849(96)00383-8 · DOI · Paper page
  42. Gridley, 1997, Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells, Brain Res, 778, 158, 10.1016/S0006-8993(97)01056-1 · DOI
  43. Pardridge, 1980, Blood-brain barrier transport and brain sequestration of steroid hormones, Am. J. Physiol, 239, E96
  44. Fischer, 1998, Blood-brain barrier permeation, J. Membr. Biol, 165, 201, 10.1007/s002329900434 · DOI · Paper page
  45. Henderson, 1994, Estrogen replacement therapy in older women, Arch. Neurol, 51, 896, 10.1001/archneur.1994.00540210068014 · DOI · Paper page
  46. Henderson, 2000, Oestrogens and dementia, Novartis Found. Symp, 230, 254, 10.1002/0470870818.ch18 · DOI
  47. Marsicano, 2002, Neuroprotective properties of cannabinoids against oxidative stress, J. Neurochem, 80, 448, 10.1046/j.0022-3042.2001.00716.x · DOI · Paper page
  48. Moosmann, 2001, Protective activity of aromatic amines and imines against oxidative nerve cell death, Biol. Chem, 382, 1601, 10.1515/BC.2001.195 · DOI
  49. Moosmann, 2000, Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins, Eur. J. Biochem, 267, 5687, 10.1046/j.1432-1327.2000.01658.x · DOI
  50. Prasad, 2000, Multiple antioxidants in the prevention and treatment of Alzheimer disease, Clin. Neuropharmacol, 23, 2, 10.1097/00002826-200001000-00002 · DOI
  51. Joseph, 2001, Copernicus revisited, Neurobiol. Aging, 22, 131, 10.1016/S0197-4580(00)00211-6 · DOI · Paper page
  52. Nunomura, 2000, Neuronal oxidative stress precedes amyloid beta deposition in Down syndrome, J. Neuropathol. Exp. Neurol, 59, 1011, 10.1093/jnen/59.11.1011 · DOI · Paper page
  53. Chapman, 2001, Genes, models and Alzheimer’s disease, Trends Genet, 17, 254, 10.1016/S0168-9525(01)02285-5 · DOI
  54. Emilien, 2000, Alzheimer disease—mouse models pave the way for therapeutic opportunities, Arch. Neurol, 57, 176, 10.1001/archneur.57.2.176 · DOI
  55. Grundman, 2000, Vitamin E and Alzheimer disease, Am. J. Clin. Nutr, 71, 630S, 10.1093/ajcn/71.2.630s · DOI · Paper page
  56. Thal, 2000, A 1-year controlled trial of acetyl-L-carnitine in early-onset AD, Neurology, 55, 805, 10.1212/WNL.55.6.805 · DOI
  57. Smith, 1997, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc. Natl. Acad. Sci. USA, 94, 9866, 10.1073/pnas.94.18.9866 · DOI · Paper page
  58. Sayre, 2001, Chemistry and biochemistry of oxidative stress in neurodegenerative disease, Curr. Med. Chem, 8, 721, 10.2174/0929867013372922 · DOI · Paper page
  59. Crapper McLachlan, 1991, Intramuscular desferrioxamine in patients with Alzheimer’s disease, Lancet, 337, 1304, 10.1016/0140-6736(91)92978-B · DOI · Paper page
  60. Münch, 1994, The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation, J. Neural Transm. Park. Dis. Dement. Sect, 8, 193, 10.1007/BF02260940 · DOI
  61. Shoda, 1997, Inhibitory effects of tenilsetam on the Maillard reaction, Endocrinology, 138, 1886, 10.1210/en.138.5.1886 · doi:10.1210/en.138.5.1886
  62. Bruce, 1996, Beta-Amyloid toxicity in organotypic hippocampal cultures, Proc. Natl. Acad. Sci. USA, 93, 2312, 10.1073/pnas.93.6.2312 · DOI · Paper page
  63. Yankner, 2000, The pathogenesis of Alzheimer’s disease. Is amyloid beta-protein the beginning or the end?, Ann. NY Acad. Sci, 924, 26, 10.1111/j.1749-6632.2000.tb05555.x · DOI
  64. Nourhashemi, 2000, Alzheimer disease, Am. J. Clin. Nutr, 71, 643S, 10.1093/ajcn/71.2.643s · DOI
  65. Vatassery, 1998, α-Tocopherol in CSF of subjects taking high-dose vitamin E in the Datatop study. Parkinson study group, Neurology, 50, 1900, 10.1212/WNL.50.6.1900 · DOI
  66. Gilgun-Sherki, 2001, Oxidative stress-induced neurodegenerative diseases, Neuropharmacology, 40, 959, 10.1016/S0028-3908(01)00019-3 · DOI · Paper page

Cited by

See all 302

Metadata

Authors
Behl, C., & Moosmann, B.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2002-07
Volume
33
Issue
2
Pages
182-191
ISSN
0891-5849 (ISSN-L)
DOI
10.1016/s0891-5849(02)00883-3
OpenAlex
W1678794149
Cited by
302
References
16
FWCI
7.90
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach2 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal. https://app.cochat.ai/papers/10.1016/s0891-5849(02)00883-3
The paper
Behl, C., & Moosmann, B. (2002). Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach2 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal. Free Radical Biology and Medicine. https://doi.org/10.1016/s0891-5849(02)00883-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.